|

Artificial Intelligence in Mammography Screening in Norway

RECRUITINGN/ASponsored by Norwegian Institute of Public Health
Actively Recruiting
PhaseN/A
SponsorNorwegian Institute of Public Health
Started2024-11-25
Est. completion2026-11
Eligibility
Age50 Years – 69 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06032390

Summary

The purpose of this randomized controlled trial is to compare the number of breast cancers detected among women who had their screening mammograms interpreted by artificial intelligence (AI) in combination with one or two breast radiologists to the number of breast cancers detected after standard independent double reading in BreastScreen Norway. The aims of the study is to prove that screening interpretation with AI in combination with one or two radiologists (the intervention) is non-inferior to standard interpretation procedure.

Eligibility

Age: 50 Years – 69 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women attending the population-based mammography screening program BreastScreen Norway providing a signed, informed consent

Exclusion Criteria:

* Women attending the population-based mammography screening program BreastScreen Norway not providing a signed, informed consent

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.